Surmodics to Present at Canaccord Genuity Medical Technology and Diagnostics Forum
November 09 2016 - 8:05AM
Business Wire
Webcast is Live on Thursday, November 17, at
8:20 a.m. (ET)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that Gary Maharaj, president and chief
executive officer, and Andy LaFrence, vice president of finance and
information systems and chief financial officer, will make a
presentation to the investment community at the Canaccord Genuity
Medical Technology and Diagnostics Forum in New York City on
Thursday, November 17, 2016, at 8:20 a.m. ET
(7:20 a.m. CT).
A live audio webcast of the presentation will be available by
going to the investor relations portion of the Company’s website at
www.surmodics.com and clicking on the webcast icon. The webcast
will be archived on the Company’s website for 90 days
following the meeting.
About Surmodics, Inc.Surmodics is the global leader in
surface modification technologies for intravascular medical devices
and a leading provider of chemical components for in vitro
diagnostic (IVD) tests and microarrays. Following two recent
acquisitions of Creagh Medical and NorMedix, the Company is
executing a key growth strategy for its medical device business by
expanding to offer total intravascular product solutions to its
medical device customers. The combination of proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities, enables Surmodics to significantly
increase the value it offers with highly differentiated
intravascular solutions designed and engineered to the most
demanding requirements. With this focus on offering total
solutions, Surmodics’ mission remains to improve the detection and
treatment of disease. Surmodics is headquartered in Eden Prairie,
Minnesota. For more information about the company, visit
www.surmodics.com. The content of Surmodics’ website is not part of
this press release or part of any filings that the company makes
with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161109005159/en/
Surmodics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024